Seroepidemiological studies of group B streptococcus type II

Academic Article

Abstract

  • In the course of prospective epidemiological studies of group B streptococcal (GBS) colonization and infection, we surveyed 401 paired maternal and cord sera (obtained at delivery) and 23 sera from patients with systemic type II infection for IgG antibody to GBS type II. Type II carriers were more likely to have antibody (>2 μg/ml) than were those carrying other GBS types, whereas noncolonized patients were the least likely to have antibody. The overall prevalence of levels of antibody >2 μg/ml was estimated to be □6%, on the basis of assay results of the 401 maternal-cord pairs and adjusted for known-colonization status for the entire population of 8, 928 deliveries that occurred during the study period. The majority of patients with infection had antibody levels <2 μg/ml. Five patients, however, had antibody present at levels ranging from 2.7 to 5.8 μg/ml. These findings suggest that “antibody deficiency” was widespread and was not by itself a useful determinant of risk for disease caused by GBS type II. © 1985 by The University of Chicago.
  • Authors

    Published In

    Digital Object Identifier (doi)

    Author List

  • Gray BM; Pritchard DG; Dillon HC
  • Start Page

  • 1073
  • End Page

  • 1080
  • Volume

  • 151
  • Issue

  • 6